Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Jansen

Showing results (241-250 of 254) with videos related to

Pageof 26
Sort By:
The New England Journal of Medicine|March 19, 2015
Polysaccharide conjugate vaccine against pneumococcal pneumonia in adultsMarc J M Bonten, Susanne M Huijts, Marieke Bolkenbaas, et al.
The New England Journal of Medicine|April 5, 2023
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older AdultsEdward E Walsh, Gonzalo Pérez Marc, Agnieszka M Zareba, et al.
The New England Journal of Medicine|March 23, 2022
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 VaccineEdson D Moreira, Nicholas Kitchin, Xia Xu, et al.
The Lancet. Oncology|May 3, 2005
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trialLuisa L Villa, Ronaldo L R Costa, Carlos A Petta, et al.
The New England Journal of Medicine|November 9, 2021
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of AgeEmmanuel B Walter, Kawsar R Talaat, Charu Sabharwal, et al.
Vaccine|June 7, 2006
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18Luisa L Villa, Kevin A Ault, Anna R Giuliano, et al.
Infection and Immunity|March 23, 2006
A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis modelNelly A Kuklin, Desmond J Clark, Susan Secore, et al.
The New England Journal of Medicine|February 15, 2023
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of AgeFlor M Muñoz, Lawrence D Sher, Charu Sabharwal, et al.
Nature|January 20, 2021
Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and T<sub>H</sub>1 T cell responsesUgur Sahin, Alexander Muik, Evelyna Derhovanessian, et al.
Nature|September 30, 2020
COVID-19 vaccine BNT162b1 elicits human antibody and T<sub>H</sub>1 T cell responsesUgur Sahin, Alexander Muik, Evelyna Derhovanessian, et al.
Pageof 26

Showing results (241-250 of 254) with videos related to

Sort By:
Pageof 26
The New England Journal of Medicine|March 19, 2015
Polysaccharide conjugate vaccine against pneumococcal pneumonia in adultsMarc J M Bonten, Susanne M Huijts, Marieke Bolkenbaas, et al.
The New England Journal of Medicine|April 5, 2023
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older AdultsEdward E Walsh, Gonzalo Pérez Marc, Agnieszka M Zareba, et al.
The New England Journal of Medicine|March 23, 2022
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 VaccineEdson D Moreira, Nicholas Kitchin, Xia Xu, et al.
The Lancet. Oncology|May 3, 2005
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trialLuisa L Villa, Ronaldo L R Costa, Carlos A Petta, et al.
The New England Journal of Medicine|November 9, 2021
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of AgeEmmanuel B Walter, Kawsar R Talaat, Charu Sabharwal, et al.
Vaccine|June 7, 2006
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18Luisa L Villa, Kevin A Ault, Anna R Giuliano, et al.
Infection and Immunity|March 23, 2006
A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis modelNelly A Kuklin, Desmond J Clark, Susan Secore, et al.
The New England Journal of Medicine|February 15, 2023
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of AgeFlor M Muñoz, Lawrence D Sher, Charu Sabharwal, et al.
Nature|January 20, 2021
Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and T<sub>H</sub>1 T cell responsesUgur Sahin, Alexander Muik, Evelyna Derhovanessian, et al.
Nature|September 30, 2020
COVID-19 vaccine BNT162b1 elicits human antibody and T<sub>H</sub>1 T cell responsesUgur Sahin, Alexander Muik, Evelyna Derhovanessian, et al.
Pageof 26